Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer

Figure 1

Baicalin inhibited NSCLC proliferation. (a) Molecular formula of baicalin. (b–d) NCI-H460, A549, and BEAS-2B cells were treated with baicalin. Cell viability was tested by MTT assay. (e) Scheme of the tumor model of nude mice with or without baicalin treatment. (f, g) Effects of baicalin on the tumor weights and tumor volume of NSCLC tumor mice. (h) Effects of baicalin on survival in NSCLC cell-bearing nude mice.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)